Baxter said it has determined that quality issues weren't involved in the deaths of two patients who took the company's heparin products.
WSJ.com: What's News US, Wall Street Journal
Fri, 05/15/2009 - 12:31pm
Baxter said it has determined that quality issues weren't involved in the deaths of two patients who took the company's heparin products.